Study supports drug-eluting stents for STEMI patients

08/19/2013 | TCTMD.com

Drug-eluting stents beat bare-metal stents for reducing target vessel revascularization without raising the risk of stent thrombosis in STEMI patients, according to a meta-analysis published in Circulation: Cardiovascular Interventions. Researchers analyzed data from clinical trials involving 14,740 STEMI patients. "The totality of data with results from cohorts, including non-acute coronary syndrome patients, patients with diabetes mellitus, and now patients with STEMI, suggest that DES (especially EES) should be the benchmark for both efficacy and safety for future clinical trials," the authors wrote.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA